ANATOMIC STAGE III BREAST CANCER

Clinical trials for ANATOMIC STAGE III BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ANATOMIC STAGE III BREAST CANCER trials appear

Sign up with your email to follow new studies for ANATOMIC STAGE III BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug attack on Hard-to-Treat breast cancer before surgery

Disease control Recruiting now

This study is testing if adding a drug called neratinib to standard hormone therapy before surgery helps treat a specific type of breast cancer. It is for people with stage I-III lobular breast cancer that has a specific genetic change (HER2 mutation). The goal is to see if this …

Matched conditions: ANATOMIC STAGE III BREAST CANCER

Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 02:41 UTC

ANATOMIC STAGE III BREAST CANCER

Get alerted when new ANATOMIC STAGE III BREAST CANCER trials appear

New drug attack on Hard-to-Treat breast cancer before surgery